Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 23 of 99

  1. C2321006

    Pfizer Australia Pty Ltd

    Small cell lung cancer, Castration-resistant prostate cancer, Follicular lymphoma

    phase 1 other active

    1 trial

  2. C2321007

    Pfizer Australia Pty Ltd

    small cell lung cancer (SCLC), castration resistant prostate cancer (CRPC), follicular lymphoma (FL)

    phase 1 other active

    1 trial

  3. C33237/1099

    Teva Pharma GmbH

    Pain

    phase 1 small molecule completed

    1 trial

  4. C33237/1106

    Teva Pharma GmbH

    Pain

    phase 1 small molecule completed

    1 trial

  5. C3421063

    Pfizer Australia Pty Ltd

    Type 2 Diabetes Mellitus, Obesity, Overweight management

    phase 1 other active

    1 trial

  6. C4151006

    Pfizer Australia Pty Ltd

    Inflammatory bowel disease

    phase 1 other active

    1 trial

  7. C4151008

    Pfizer Australia Pty Ltd

    Inflammatory bowel disease.

    phase 1 other active

    1 trial

  8. C4161006

    Pfizer Australia Pty Ltd

    (HR) -positive human epidermal growth factor receptor 2 (HER2) -negative breast cancer (BC), non-small cell lung cancer (NSCLC), ovarian cancer, and triple negative breast cancer (TNBC)

    phase 1 other active

    1 trial

  9. C4391010

    Pfizer Australia Pty Ltd

    metastatic/advanced breast cancer

    phase 1 other active

    1 trial

  10. C4541011

    Pfizer Australia Pty Ltd

    Older adults at risk of malnutrition

    phase 1 other active

    1 trial

  11. C4551007

    Pfizer Australia Pty Ltd

    locally advanced or metastatic ER+/HER2- breast cancer

    phase 1 other active

    1 trial

  12. C4551010

    Pfizer Australia Pty Ltd

    locally advanced or metastatic HR+/HER2- breast cancer

    phase 1 other active

    1 trial

  13. C4891037

    Pfizer Australia Pty Ltd

    ER+/HER2- breast cancer

    phase 1 other active

    1 trial

  14. C4891038

    Pfizer Australia Pty Ltd

    ER+/HER2- Breast Cancer

    phase 1 other active

    1 trial

  15. C4921002

    Pfizer Australia Pty Ltd

    Heart failure

    phase 1 other active

    1 trial

  16. C4921008

    Pfizer Australia Pty Ltd

    Heart Failure

    phase 1 other active

    1 trial

  17. C4951092

    Pfizer Australia Pty Ltd

    Migraine with or without aura

    phase 1 other active

    1 trial

  18. C5091010

    Pfizer Australia Pty Ltd

    severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

    phase 1 other active

    1 trial

  19. C5091029

    Pfizer Australia Pty Ltd

    Coronavirus disease 2019

    phase 1 other active

    1 trial

  20. C5171002

    Pfizer Australia Pty Ltd

    heart failure with preserved ejection fraction

    phase 1 other active

    1 trial

  21. C5381001

    Pfizer Australia Pty Ltd

    clonal hematopoiesis

    phase 1 other active

    1 trial

  22. C5381002

    Pfizer Australia Pty Ltd

    Clonal hematopoiesis

    phase 1 other active

    1 trial

  23. C5541002

    Pfizer Australia Pty Ltd

    Obesity, Overweight

    phase 1 other active

    1 trial

  24. C5661001

    Pfizer Australia Pty Ltd

    IgA nephropathy

    phase 1 other active

    1 trial

  25. C5671001

    Pfizer Australia Pty Ltd

    CCI

    phase 1 other active

    1 trial

  26. C5911001 - SGN-CD25V

    Pfizer Australia Pty Ltd

    Advanced lymphomas (classic Hodgkin lymphoma [cHL], peripheral T cell lymphoma [PTCL], and diffuse large B cell lymphoma [DLBCL]), Solid tumors (eg, NSCLC, HNSCC, and melanoma)

    phase 1 other active

    1 trial

  27. C5951001

    Pfizer Australia Pty Ltd

    advanced solid tumors

    phase 1 other active

    1 trial

  28. C5961001

    Pfizer Australia Pty Ltd

    RSV (Respiratory Syncytial Virus)

    phase 1 other active

    1 trial

  29. C6001001

    Pfizer Australia Pty Ltd

    Non-muscle invasive bladder cancer (NMIBC)

    phase 1 other active

    1 trial

  30. C6081001

    Pfizer Australia Pty Ltd

    KRAS mutated advanced solid tumors

    phase 1 other active

    1 trial

  31. C6341001

    Pfizer Australia Pty Ltd

    Rheumatoid arthritis and Systemic Lupus Erythematosus

    phase 1 other active

    1 trial

  32. CA011-1010

    Bristol-Myers Squibb Australia Pty Ltd

    Advanced Solid Tumors

    phase 1 other active

    1 trial

  33. CA059-001

    Celgene Europe Limited

    Acute Myeloid Leukemia and Myelodysplastic Syndromes

    phase 1 other active

    1 trial

  34. CA061-1001

    Celgene Europe Limited

    Systemic Sclerosis, Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathy, Systemic Lupus Erythematosus (SLE)

    phase 1 other active

    1 trial

  35. CA061-1006

    Celgene Europe Limited

    Myasthenia gravis (MG), Progressive Multiple Sclerosis (PMS), Relapsing Multiple Sclerosis (RMS)

    phase 1 other active

    1 trial

  36. CA111-001

    Bristol-Myers Squibb Australia Pty Ltd

    Advanced Malignant Tumors

    phase 1 other active

    1 trial

  37. CA1190002

    Celgene Europe Limited

    Relapsed and/or Refractory Multiple Myeloma

    phase 1 other active

    1 trial

  38. CA127-1027

    Bristol-Myers Squibb Australia Pty Ltd

    Non-small Cell Lung Cancer (NSCLC)

    phase 1 other active

    1 trial

  39. CA177-1036

    Turn Therapeutics

    Phase 1: Advanced solid tumors harboring genetic alterations in MET

    phase 1 other active

    1 trial

  40. CA235-0001

    Bristol-Myers Squibb Australia Pty Ltd

    Acute Myeloid Leukemia and Myelodysplastic Syndrome

    phase 1 other active

    1 trial

  41. CA240-0008

    Bristol-Myers Squibb Australia Pty Ltd

    Advanced Solid Tumors

    phase 1 other active

    1 trial

  42. CA243-0001

    Bristol-Myers Squibb Australia Pty Ltd

    Advanced or metastatic solid tumors, Gastroesophageal cancer (GEC), High grade serous ovarian cancer (HGSOC), Endometrial cancer (EC), Advanced or metastatic breast cancer, Platinum-resistant ovarian cancer (PROC)

    phase 1 other active

    1 trial

  43. CAAA601A52101

    Novartis Pharmaceuticals

    Glioblastoma

    phase 1 other active

    1 trial

  44. CAAA603C12101

    Novartis Pharmaceuticals

    Glioblastoma

    phase 1 other active

    1 trial

  45. CAAA617A12101

    Novartis Pharmaceuticals

    Metastatic Castration-Resistant Prostate Cancer

    phase 1 small molecule active

    1 trial

  46. CABG + Mitral valve annuloplasty

    United Therapeutics Europe Ltd

    Mitral Regurgitation

    phase 1 other completed

    1 trial

  47. CADPT01C12101

    Novartis Pharmaceuticals

    Advanced or metastatic BRAF V600 colorectal cancer.

    phase 1 other active

    1 trial

  48. CAIN457E22101

    Novartis Pharmaceuticals

    Polymyalgia rheumatica (PMR), Giant cell arteritis (GCA)

    phase 1 other active

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.